Valuation: Burning Rock Biotech Limited

Capitalization 120.2Cr 18Cr 15Cr 14Cr 13Cr 24Cr 1.67TCr 24Cr 163.03Cr 64Cr 801.85Cr 66Cr 65Cr 2.77TCr P/E ratio 2024
-1.46x
P/E ratio 2025 -27.1x
Enterprise value 76Cr 11Cr 9.55Cr 8.74Cr 8.25Cr 15Cr 1.06TCr 16Cr 103.67Cr 40Cr 509.89Cr 42Cr 41Cr 1.76TCr EV / Sales 2024
0.06x
EV / Sales 2025 2x
Free-Float
61.34%
Yield 2024 *
-
Yield 2025 -
1 day+1.09%
1 week-1.96%
Current month-1.41%
1 month+3.14%
3 months-45.39%
6 months+42.15%
Current year-16.82%
1 week 16.16
Extreme 16.158
17.76
1 month 15.42
Extreme 15.42
22.5
Current year 15.4
Extreme 15.4
41.72
1 year 2.26
Extreme 2.26
41.72
3 years 2.18
Extreme 2.18
41.72
5 years 2.18
Extreme 2.18
386.4
10 years 2.18
Extreme 2.18
397.5
Manager TitleAgeSince
Corporate Officer/Principal - 01/01/2014
Chief Executive Officer 48 01/01/2014
Director of Finance/CFO - 27/09/2024
Director TitleAgeSince
Chairman 48 -
Director/Board Member 55 01/06/2014
Director/Board Member 63 01/08/2016
Change 5d. change 1-year change 3-years change Capi.($)
+1.09%-1.96%+620.86%-41.40% 18Cr
+0.45%-4.21%+3.18%-5.36% 806.76Cr
+1.28%+2.25% - - 166.27Cr
-0.20%-1.90%+6.86%-6.67% 133.14Cr
-0.65%+0.45%-8.17%-28.53% 97Cr
+1.91%+6.58%+141.93%+75.11% 94Cr
+0.48%+0.38%+4.79% - 72Cr
0.00%-1.12%-16.43%-11.26% 39Cr
-4.28%-4.28%-48.93%-79.65% 27Cr
-0.85%-0.09%+9.68%+39.34% 22Cr
Average -0.08%-0.40%+79.31%-7.30% 147.54Cr
Weighted average by Cap. +0.40%-1.93%+19.53%-2.76%

Financials

2024 2025
Net sales 52Cr 7.59Cr 6.44Cr 5.9Cr 5.57Cr 10Cr 716.35Cr 10Cr 70Cr 27Cr 344.09Cr 28Cr 28Cr 1.19TCr 54Cr 7.93Cr 6.74Cr 6.17Cr 5.82Cr 11Cr 749.33Cr 11Cr 73Cr 29Cr 359.93Cr 30Cr 29Cr 1.24TCr
Net income -35Cr -5.1Cr -4.33Cr -3.96Cr -3.74Cr -6.98Cr -481.38Cr -7.04Cr -47Cr -18Cr -231.23Cr -19Cr -19Cr -798.29Cr -5.53Cr -81.39L -69.14L -63.28L -59.73L -1.11Cr -77Cr -1.12Cr -7.51Cr -2.93Cr -37Cr -3.05Cr -2.99Cr -127.46Cr
Net Debt -47Cr -6.97Cr -5.92Cr -5.42Cr -5.11Cr -9.53Cr -657.81Cr -9.62Cr -64Cr -25Cr -315.97Cr -26Cr -26Cr -1.09TCr -44Cr -6.44Cr -5.47Cr -5Cr -4.72Cr -8.81Cr -607.82Cr -8.89Cr -59Cr -23Cr -291.96Cr -24Cr -24Cr -1.01TCr
Logo Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
Employees
667
Date Price Change Volume
08/26/08 16.76 $ +1.09% 8,192
07/26/07 16.58 $ -2.53% 2,005
06/26/06 17.01 $ -0.09% 3,590
05/26/05 17.02 $ -0.96% 8,643
04/26/04 17.19 $ +0.56% 6,416